[SYRE] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
29-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -57.53%
YoY- -235.67%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 0 0 0 1,042 0 688 198 -
PBT -69,010 -38,837 -43,825 -63,180 -40,104 -217,074 -18,458 140.31%
Tax -18 0 -32 -5,746 3 7 -36 -36.92%
NP -69,028 -38,837 -43,857 -63,180 -40,107 -217,081 -18,422 140.66%
Tax Rate - - - - - - - -
Total Cost 69,028 38,837 43,857 64,222 40,107 217,769 18,620 138.96%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 0.00 0.00 0.00 -6,063.34 0.00 -31,552.47 -9,304.04 -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -1.36 -0.86 -1.20 -11.29 -9.34 -56.79 -4.89 -57.29%
EPS Diluted -1.36 -0.86 -1.20 -11.29 -9.34 -56.79 -4.89 -57.29%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.